Will ‘Zantac’ be substituted by domestic generics?

GSK’s Zantac, the original of ranitidine, went out of stock again. The distribution industry and pharmacies have started to make complaints. Using it as a chance, some generic products are also known to aggressively target the market.

Zantac, which had kept KRW 1 billion annual sales until the year of 2012, has made significant growths as recording KRW 3 billion and KRW 3.5 billion last year a...